Member access

4-Traders Homepage  >  Shares  >  Nasdaq  >  Catalyst Pharmaceutical Partners, Inc.    CPRX   US14888U1016

 SummaryQuotesChartsNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
Quotes 5-day view   Delayed Quote. Delayed Nasdaq
02/24/2015 02/25/2015 02/26/2015 02/27/2015 03/02/2015 Date
3.73(c) 3.7(c) 3.78(c) 3.76(c) 3.76(c) Last
1 035 149 1 546 927 802 821 466 267 475 528 Volume
+6.27% -0.80% +2.16% -0.53% 0.00% Change
More quotes
Company
Catalyst Pharmaceutical Partners, Inc. is a development-stage specialty pharmaceutical company, which focuses on the development and commercialization of prescription drugs targeting addiction and diseases of the central nervous system with a focus on the treatment of drug addiction and... 
Sector
Biotechnology & Medical Research
Calendar
03/10 | 12:30pmPresentation
More about the company
Surperformance© ratings of Catalyst Pharmaceutical Pa
Trading Rating : Investor Rating : -
More Ratings
Chart CATALYST PHARMACEUTICAL PA
Duration : Period :
Catalyst Pharmaceutical Pa Technical Analysis Chart | CPRX | US14888U1016 | 4-Traders
Full-screen chart
Financials ($)
Sales 2014 -
EBIT 2014 -15,2 M
Net income 2014 -16,0 M
Debt 2014 -
Yield 2014 -
Sales 2015 -
EBIT 2015 -16,1 M
Net income 2015 -24,0 M
Debt 2015 -
Yield 2015 -
PER 2014 -
PER 2015
Capi. / Sales 2014 0
Capi. / Sales 2015 0
Capitalization 303 M
More Financials
Latest news on CATALYST PHARMACEUTICAL PA
02/20 CATALYST PHARMACEUTICAL PARTNERS : Pharmaceuticals Announces Appointment of Rich..
02/20 CATALYST PHARMACEUTICAL PARTNERS : Change in Directors or Principal Officers, Fi..
02/19 Catalyst Pharmaceuticals Announces Appointment of Richard J. Daly and Donald ..
02/09 Catalyst Pharmaceutical Partners, Inc. Announces Closing of Previously Announ..
02/04 CATALYST PHARMACEUTICAL PARTNERS : Entry into a Material Definitive Agreement, F..
02/04 Catalyst Pharmaceutical Partners, Inc. Prices Public Offering of Common Stock
02/03 Catalyst Pharmaceutical Partners, Inc. Announces Commencement of Public Offer..
02/02 CATALYST PHARMACEUTICAL PARTNERS : Other Events, Financial Statements and Exhibi..
More news
Sector news Bio Therapeutic Drugs
06:18p PUMA BIOTECHNOLOGY : Biotech reports 4Q loss
04:17p PUMA BIOTECHNOLOGY : Reports Fourth Quarter and Full Year 2014 Financial Results
08:22a ACTELION : Selexipag (Uptravi) data in pulmonary arterial hypertension to be pre..
Plus d'actualités du secteur Bio Therapeutic Drugs


Comments 
Advertisement
Technical analysis trends
Short TermMid-TermLong Term
TrendsBullishBullishBullish
Technical analysis
Income Statement Evolution
More Financials
EPS Revisions
More Estimates Revisions
Dynamic quotes  
ON
| OFF